(Q44124507)

30 November 2017

title

Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer (English)

1 reference

30 November 2017

Xiaohui Duan

1

1 reference

30 November 2017

Langmei Deng

2

1 reference

30 November 2017

Xiong Chen

3

1 reference

30 November 2017

Yebin Lu

4

1 reference

30 November 2017

Qi Zhang

5

1 reference

30 November 2017

Kejing Zhang

6

1 reference

30 November 2017

Yongjun Hu

7

1 reference

30 November 2017

Jie Zeng

8

1 reference

30 November 2017

Weijia Sun

9

1 reference

30 November 2017

publication date

31 March 2010

1 reference

30 November 2017

1 reference

30 November 2017

volume

28

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

466-474

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-010-9480-9

30 November 2017

exact match

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Pancreatic cancer mortality in Europe: the leveling of an epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Roles of the NKG2D immunoreceptor and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Soluble MICA in malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9480-9

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

21 January 2018

1 reference

12 December 2020

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity

1 reference

12 December 2020

Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract

1 reference

12 December 2020

Expression of stress-induced MHC class I related chain molecules on human melanoma

1 reference

12 December 2020

Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer

1 reference

12 December 2020

Role of natural killer cells in cancer.

1 reference

12 December 2020

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients

1 reference

12 December 2020

10.1007/S12032-010-9480-9

Identifiers

DOI

1 reference

release_pwzueo6wo5gsromi2uvdouawwu

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pwzueo6wo5gsromi2uvdouawwu

24 November 2022

mapped directly with Wikidata item

1 reference